NEWS
KalVista to present HAE attack journey data at 2024 HAEi Regional Conference Americas
KalVista Pharmaceuticals to present HAE attack journey data at 2024 HAEi Regional Conference Americas KalVista Pharmaceuticals today announced the acceptance of multiple abstracts at the 2024 HAEi Regional Conference meeting taking place in Panama [...]
Astria reports Q4 and full year 2023 financial results and provides a corporate update
Astria Therapeutics reports fourth quarter and full year 2023 financial results and provides a corporate update Astra Therapeutics today announced today reported financial results for the fourth quarter and full year ended 31 December [...]
BioCryst reports Q4 and full year 2023 financial results and upcoming key milestones
BioCryst reports fourth quarter and full year 2023 financial results and upcoming key milestones Biocryst Pharmaceuticals Inc today reported financial results for the fourth quarter and full year ended 31 December 2023, and provided [...]
KalVista presents additional phase-3 KONFIDENT data at the 2024 AAAAI Annual Meeting
KalVista Pharmaceuticals presents additional phase-3 KONFIDENT data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting KalVista Pharmaceuticals today announced that it presented additional data on its phase 3 KONFIDENT trial [...]
KalVista presents data on unmet needs in HAE from a Patient Perspective at the 2024 AAAAI Annual Meeting
KalVista Pharmaceuticals presents data on unmet needs in HAE from a Patient Perspective at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting KalVista Pharmaceuticals today announced that it presented real-world data [...]
BioCryst presents new real-world data showing rapid, substantial and sustained HAE attack rate reductions after beginning Orladeyo (berotralstat) treatment
BioCryst presents new real-world data showing rapid, substantial and sustained HAE attack rate reductions after beginning Orladeyo (berotralstat) treatment Biocryst Pharmaceuticals Inc today announced new analyses of real-world use of oral, once-daily Orladeyo (berotralstat) [...]
Intellia announces Q4 and full-year 2023 financial results and highlights company progress
Intellia Therapeutics announces fourth quarter and full-year 2023 financial results and highlights recent company progress Intellia Therapeutics today reported operational highlights and financial results for the fourth quarter and year ended December 31, 2023. [...]
Positive Results from CHAPTER-1 Phase 2 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks to be Presented at AAAAI 2024 Annual Meeting
Positive Results from CHAPTER-1 Phase 2 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks to be Presented at AAAAI 2024 Annual Meeting Pharvaris today announced the upcoming presentation of two posters at [...]
Astria to present at upcoming AAAAI Annual Meeting
Astria Therapeutics to present at upcoming American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting Astra Therapeutics today announced that it will present final STAR-0215 Phase 1a healthy subject data at the upcoming [...]
BioCryst launches Orladeyo (berotralstat) in Italy
BioCryst launches Orladeyo (berotralstat) in Italy BioCryst Pharmaceuticals Inc today announced that the Italian Medicines Agency, Agenzia Italiana del Farmaco (AIFA), has finalized reimbursement and recommended Orladeyo (berotralstat) for the routine prevention of recurrent [...]
KalVista awarded UK innovation passport for sebetralstat
KalVista Pharmaceuticals awarded UK innovation passport for sebetralstat KalVista Pharmaceuticals today announced the UK Medicines and Healthcare products Regulatory Agency (MHRA) has awarded the Innovation Passport for sebetralstat, an investigational novel, oral plasma kallikrein [...]
KalVista to present phase-3 sebetralstat data at the 2024 AAAAI Annual Meeting
KalVista Pharmaceuticals to present phase-3 sebetralstat data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting KalVista Pharmaceuticals today announced the acceptance of multiple abstracts at the 2024 American Academy of [...]
KalVista reports phase-3 KONFIDENT trial meets all endpoints for sebetralstat as first oral on-demand therapy for HAE
KalVista Pharmaceuticals reports phase-3 KONFIDENT trial meets all endpoints for sebetralstat as first oral on-demand therapy for hereditary angioedema KalVista Pharmaceuticals today announced positive results from the phase 3 KONFIDENT clinical trial demonstrating statistically [...]
CSL reports net profit after tax for six months ending 31 Dec 2023
CSL reports net profit after tax for six months ending 31 December 2023 CSL Limited announced a reported net profit after tax of $1.90 billion1 for the 6 months that ended 31 December 2023, [...]
BioCryst to present new Orladeyo (berotralstat) real-world data at 2024 AAAAI annual meeting
BioCryst to present new Orladeyo (berotralstat) real-world data at 2024 American Academy of Allergy, Asthma & Immunology annual meeting BioCryst Pharmaceuticals Inc today announced that the company will present five abstracts featuring new analyses [...]
Intellia announces publication of positive interim phase 1 data for NTLA-2002 in HAE patients
Intellia Therapeutics announces publication in the New England Journal of Medicine of positive interim phase 1 data for NTLA-2002 in patients with hereditary angioedema Intellia Therapeutics announced that interim results from the Phase 1 [...]
News from Venezuela
From Wilfredo Bocaranda, President, HAE Venezuela HAE Venezuela held meetings with the Authorities of the Military Hospital with Doctors Guillermo Boggiano, Rommy Boggiano, and their medical team to analyze the case of patients in [...]
News from USA
From Jess Myers, Communication and Advocacy Specialist, US HAEA US HAEA Advocacy Update: The US HAEA advocacy team has been hard at work this year to fight against harmful policies that prevent Americans with [...]
News from the UK
From Angela Metcalfe, CEO of HAE UK Goodness, it has been a very busy year for HAE UK! As CEO, I was delighted to attend the 2023 HAEi Regional Conference EMEA in Munich at [...]
News from Tunisia
From HAE Tunisia The “ANAOH Tunisia” association officially began its activities in October 2022 with an executive office bringing together four patients and four doctors. The first general meeting was held in March 2023 [...]
News from Switzerland
From Helene Saam, President, HAE Switzerland The highlights in 2023 for the Swiss HAE Association were as follows: Production of the film ‘HAE - Simply Explained’ >> Watch the film with German, English, French, [...]
News from South Korea
From Soojin Min, HAE Korea Start of Welfare for the Weak! National Assembly Debate to Improve the Quality of Life of Patients with Rare Diseases in Medical Blind Spots: On Tuesday, 12 September, The [...]
News from South Africa
From Janice Strydom, HAE South Africa HAE SA started 2023 with the exciting announcement that icatibant, our first treatment for acute attacks of HAE, had been registered. This is a significant milestone for our [...]
News from Slovenia
From Teja Iskra, HAE Slovenia After years of struggle and struggle, my family once again helped me so that I could fulfill my dreams. Finally, I can proudly say that the HAE Slovenia Patient [...]
News from Singapore
From Lim Yong Hao, HAE Singapore HAE Singapore’s membership has recently broken into double digits with 11 members, consisting of patients and caregivers. We are slowly growing and hope to reach and engage the [...]
Stay Tuned
Be the first to know what’s going on in the world of HAE
Upcoming events
Mar 15, 2024 - Mar 17, 2024
2024 HAEi Regional Conference Americas
Czech Republic
Apr 12, 2024 - Apr 14, 2024
Family Educational Camp; organized by HAE Junior Czech Republic
Saudi Arabia
May 11, 2024
HAE Patient Workshop; HAE Saudi Arabia
May 16, 2024
hae day :-) 2024
HAE related topics that might interest you
Global Perspectives
Magazine with timely information on the issues, activities, and events that are relevant to the global HAE community
HAEi Advocacy Academy
Courses, advocacy training, and tools to support people living with HAE and becoming an HAE advocate
HAEi Connect Member database
Free, secure online membership database and communications platform for HAEi’s member organizations
HAE Companion app
Access to HAEi’s emergency card in many languages and ACARE Centers, HAE knowledgeable hospitals and physicians
Stay tuned – sign up for our newsletter
BE THE FIRST TO KNOW ABOUT HAE NEWS, TREATMENTS, EVENTS AND RELATED TOPICS